AG
AEGR

Advisor Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Advisor Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,900
Closed -$9K – 4789
2016
Q3 		$9K Hold
2,900
– – ﹤0.01% 3655
2016
Q2 		$4K Buy
+2,900
New +$6.63K ﹤0.01% 3933

Advisor Group's AEGR Position: Q4 2016 in Review

Advisor Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 2,900 shares — an estimated $9K sold.

Advisor Group first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $9K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Advisor Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Advisor Group sold 2,900 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $9K.
  • Advisor Group first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
  • Advisor Group's Aegerion Pharmaceuticals position peaked at $9K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Advisor Group's 13F filing for Q4 2016, filed 31 Jan 2017.